These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1840013)

  • 41. The involvement of D1 and D2 dopamine receptors in amphetamine-induced changes in striatal unit activity in behaving rats.
    Rosa-Kenig A; Puotz JK; Rebec GV
    Brain Res; 1993 Aug; 619(1-2):347-51. PubMed ID: 8374790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. D1, but not D2, receptor blockade within the infralimbic and medial orbitofrontal cortex impairs cocaine seeking in a region-specific manner.
    Cosme CV; Gutman AL; Worth WR; LaLumiere RT
    Addict Biol; 2018 Jan; 23(1):16-27. PubMed ID: 27578356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of dopamine D1 and D2 receptor antagonists on oral activity in rats.
    Levin ED; See RE; South D
    Pharmacol Biochem Behav; 1989 Sep; 34(1):43-8. PubMed ID: 2576312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of dopamine receptor subtypes in mouse thermoregulation.
    Zarrindast MR; Tabatabai SA
    Psychopharmacology (Berl); 1992; 107(2-3):341-6. PubMed ID: 1535446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P; Boyson SJ; Reuter S; Molinoff PB
    Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral stereotypies induced by "binge' cocaine administration are independent of drug-induced increases in corticosterone levels.
    Spangler R; Zhou Y; Schlussman SD; Ho A; Kreek MJ
    Behav Brain Res; 1997 Jul; 86(2):201-4. PubMed ID: 9134155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subtypes of dopamine receptors involved in the mechanism of reinforcement.
    Nakajima S
    Neurosci Biobehav Rev; 1989; 13(2-3):123-8. PubMed ID: 2530477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholinergic maturation and SCH 23390-induced catalepsy in the male rat pup.
    Fitzgerald LW; Hannigan JH
    Brain Res Dev Brain Res; 1989 May; 47(1):147-50. PubMed ID: 2525433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats.
    Maldonado R; Daugé V; Feger J; Roques BP
    Neuropharmacology; 1990 Mar; 29(3):215-23. PubMed ID: 2157999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors.
    McDougall SA; Crawford CA; Nonneman AJ
    Psychopharmacology (Berl); 1993; 111(2):225-32. PubMed ID: 7870957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On the selectivity and specificity of the antagonism of apomorphine-induced suppression of exploration by sulpiride.
    Ståhle L; Ungerstedt U
    Psychopharmacology (Berl); 1989; 99(1):75-9. PubMed ID: 2528780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area.
    Esmaeili MH; Kermani M; Parvishan A; Haghparast A
    Behav Brain Res; 2012 May; 231(1):111-5. PubMed ID: 22426507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine in the prefrontal cortex regulates rats behavioral flexibility to changing reward value.
    Winter S; Dieckmann M; Schwabe K
    Behav Brain Res; 2009 Mar; 198(1):206-13. PubMed ID: 19041903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
    Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1985 Mar; 109(3):349-54. PubMed ID: 3157586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
    Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
    Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.